Efficacy, Safety and Pharmacokinetics of BCD-100 (Anti-PD-1) Monotherapy as Second Line Treatment in Patients With Non-Small Cell Lung Cancer (DOMINUS)
Clinical trial NCT03288870 · UNKNOWN
Trial details
- NCT number
- NCT03288870
- Sponsor
- Biocad
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-19
- Primary completion
- 2020-08-10
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.